83803-81-0

Basic information

• Product Name: ethyl 4,4-dimethoxy-3-methyl-2-butenoate
• Synonyms: ethyl 4,4-dimethoxy-3-methyl-2-butenoate;4,4-Dimethoxy-3-methyl-2-butenoic acid ethyl ester;Einecs 280-901-5
• CAS NO: 83803-81-0
• Molecular Formula: C₉H₁₆O₄
• Molecular Weight: 188.22094
• EINECS: 280-901-5
• Mol File: 83803-81-0.mol

Chemical Properties

• Boiling Point: 240.4°C at 760 mmHg
• Flash Point: 97.5°C
• Appearance: /
• Density: 1.006g/cm³
• Vapor Pressure: 0.0381mmHg at 25°C
• Refractive Index: 1.435
• CAS DataBase Reference: ethyl 4,4-dimethoxy-3-methyl-2-butenoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4,4-dimethoxy-3-methyl-2-butenoate(83803-81-0)
• EPA Substance Registry System: ethyl 4,4-dimethoxy-3-methyl-2-butenoate(83803-81-0)

Safety Data

• Hazardous Substances Data: 83803-81-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H16O4/c1-5-13-8(10)6-7(2)9(11-3)12-4/h6,9H,5H2,1-4H3/b7-6+

Upstream product

• 867-13-0 diethoxyphosphoryl-acetic acid ethyl ester 
• 6342-56-9 Pyruvic aldehyde dimethyl acetal 
• 90208-14-3 ethyl 2-(diethoxyphosphoryl)acetate lithium salt 

Downstream Products

• 62054-49-3 ethyl (E)-3-formyl-2-butenoate 
• 54709-94-3 5-methylpyridazin-3(2H)-one 
• 966-47-2 3-methoxy-estra-1,3,5⁽¹⁰⁾,8⁽⁹⁾,14⁽¹⁵⁾-pentaene-17-one 
• 110625-77-9 (S)-benzyloxy-1-ethoxymethoxy-2-methylbutane 
• 116-31-4 all-trans-Retinal 
• 302-79-4 all-trans-retinoic-acid 
• 68-26-8 RETINOL 
• 118353-70-1 tBDMS-retinol 
• 118304-71-5 (2E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,8-dien-5-yne-1,4,7-triol 
• 118272-45-0 9-(2',6',6'-trimethyl-1'-cyclohexen-1'-yl)-3,7-dimethyl-1-<(tert-butyldimethylsilyl)oxy>-(2E,5Z,8E)-nona-2,5,8-triene-4,7-diol 
• 118272-45-0 9-(2',6',6'-trimethyl-1'-cyclohexen-1'-yl)-3,7-dimethyl-1-<(tert-butyldimethylsilyl)oxy>-(2E,5E,8E)-nona-2,5,8-triene-4,7-diol 
• 118282-96-5 (1E,7E)-9-(tert-Butyl-dimethyl-silanyloxy)-3,7-dimethyl-1-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-1,7-dien-4-yne-3,6-diol 
• 95286-43-4 ethyl 9-(2',6',6'-trimethyl-1'-cyclohexen-1'-yl)-3,7-dimethyl-4,7-dihydroxy-(2E,8E)-nona-2,8-dien-5-ynoate 
• 40834-42-2 5-hydroxy-4-methyl-5H-furan-2-one 

Relevant articles and documents

Toward Leiodermatolide: Synthesis of the Core Structure

The macrocyclic core (35) of the marine natural product leiodermatolide (1) was synthesized from two key fragments, vinyl iodide 23 (C1-C11 part) and vinyl stannane 31 (C12-C18 part). A Stille coupling led to conjugated Z,Z-diene 32. The derived seco acid 34 was cyclized using a Yamaguchi macrolactonization. Key steps in the assembly of vinyl iodide 23 were a Paterson aldol reaction, and a Kumada coupling on a triflate derivative to create the C4-C5 trisubstituted double bond. The two stereocenters in fragment 31 were established by a Marshall-Tamaru reaction. The longest linear sequence comprises 20 steps.

Process for total synthesis of pladienolide B and pladienolide D

[Problems to be Solved] To provide an effective process for total synthesis of pladienolide B and pladienolide D having excellent anti-tumor activity and to provide useful intermediates in the above-described process. [Measure for Solving the Problem] A process for producing a compound represented by Formula (11): wherein P1, P7, P8, P9 and R1 are the same as defined below, characterized by including reacting a compound represented by Formula (12): wherein P7 means a hydrogen atom or a protecting group for hydroxy group; R1 means a hydrogen atom or a hydroxy group, with a compound represented by Formula (13): wherein P1 means a hydrogen atom or a protecting group for hydroxy group; P8 means a hydrogen atom, an acetyl group or a protecting group for hydroxy group; P9 means a hydrogen atom or a protecting group for hydroxy group; or P8 and P9 may form together a group represented by a formula: wherein R5 means a phenyl group which may have a substituent, in the presence of a catalyst.

Total synthesis of the potent antitumor macrolides pladienolide B and D

Getting cross: The total syntheses of two pladienolides (see picture), which have prominent antitumor activity based on a unique mechanism of action, have been accomplished, and their absolute configurations were verified. The 12-membered aliphatic macrolide structure was formed by ring-closing metathesis, and the side-chain moiety was coupled to the macrolide by Julia-Kocienski olefination or cross-metathesis. (Chemical Equation Presented).

Simple, Catalytic Enantioselective Syntheses of Estrone and Desogestrel

Highly enantioselective and very short syntheses of the bioactive forms of estrone (3) and desogestrel (4) are described using a chiral oxazaborolidinium catalyst (2) in the key initial step. Enantiomerically pure estrone was synthesized in eight steps from the readily available starting materials diene 5 and α,β-enal 6 via intermediates 8 and 9. Desogestrel was synthesized using a similar strategy from diene 5 and α,β-enal 11 via intermediates 12-17. The efficient syntheses of the chiral catalyst 2 and its enantiomer are also presented. Copyright

Triene compounds having a chromene structure

Compounds of general formula (I): STR1 in which: R1, R2, R3 and R4, which may be identical or different, denote a hydrogen atom, a halogen atom or a lower alkyl, lower alkenyl, lower alkyloxy or lower alkenyloxy group, optionally substituted with one or more halogen atoms, R5 denotes a carboxyl, (lower alkyloxy)carbonyl, (lower alkenyloxy)carbonyl or (lower alkynyloxy)-carbonyl, their isomers, stereoisomers and diastereoisomers, and also their addition salts with a pharmaceutically acceptable base. Medicinal products.

Synthesis of New Aromatic Retinoid Analogues by Low-Valent Titanium Induced Reductive Elimination

The low-valent titanium reductive elimination reaction, already applied to the stereospecific synthesis of vitamin A and 13-cis-retinol, was used to prepare several retinoic acid analogues in the all-trans configuration or in the 13-cis configuration.This highly stereospecific trans-diene formation allowed an improved synthesis of the title compounds without any purification of the intermediates before the final stage.

HIGHLY STEREOSELECTIVE SYNTHESIS OF VITAMIN A AND ALL-TRANS RETINOIC ACID BY LOW-VALENT TITANIUM INDUCED REDUCTIVE ELIMINATION

Application of the low-valent Titanium induced reductive elimination gave a new and highly stereoselective approach to vitamin A and all-trans retinoic acid.

A NEW SYNTHESIS OF Δ2-BUTENOLIDES VIA STEREOSELECTIVE FORMATION OF α,β-ETHYLENIC ESTERS

A new synthesis of Δ2-butenolides is described which involves stereoselective condensation of an α-silyl ester anion with an α-ketoacetal.